Josh Brumm
2022
In 2022, Josh Brumm earned a total compensation of $4.3M as Former President and Chief Executive Officer at Dyne Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $335,500 |
|---|---|
| Option Awards | $1,661,236 |
| Salary | $610,000 |
| Stock Awards | $1,709,371 |
| Other | $996 |
| Total | $4,317,103 |
Brumm received $1.7M in stock awards, accounting for 40% of the total pay in 2022.
Brumm also received $335.5K in non-equity incentive plan, $1.7M in option awards, $610K in salary and $996 in other compensation.
Rankings
In 2022, Josh Brumm's compensation ranked 782nd out of 5,760 executives tracked by ExecPay. In other words, Brumm earned more than 86.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 782 out of 5,760 | 86th |
Division Manufacturing | 354 out of 3,136 | 89th |
Major group Chemicals And Allied Products | 118 out of 1,422 | 92nd |
Industry group Drugs | 105 out of 1,323 | 92nd |
Industry Pharmaceutical Preparations | 77 out of 969 | 92nd |
Source: SEC filing on April 5, 2024.
Brumm's colleagues
We found three more compensation records of executives who worked with Josh Brumm at Dyne Therapeutics in 2022.